×
Still, the cost was so high that in 1992, the federal Office of Technology Assessment, conducted an investigation into the development of the drug. The report estimated Genzyme spent $29.4 million to develop the drug. It said much of the initial research was done by scientists at the NIH and paid for by the government. - www.wsj.com